Answers are grounded in this paper and cite their sources.
The prevalence of type 2 diabetes mellitus (T2DM) in Jordan is a significant public health challenge, with glucose management frequently remaining suboptimal. The aim was to assess the impact of a culturally tailored telehealth education programme on glycemic management and self-care behaviours in Jordanian adults with T2D M. We conducted a two-arm, parallel-group, randomised controlled trial in outpatient diabetes clinics in Amman, Jordan. A total of 104 adults with elevated HbA1c levels (HbA1c 7.5–11%) were randomized (1:1) to either a 6-month intervention or standard care (control). The low-burden intervention consisted of educational content via WhatsApp broadcasts and personalised telephonic coaching for goal-setting. The primary outcome was the change in HbA1c whereas secondary included self-care behaviours, medication adherence, diabetes knowledge, and diabetes fatalism, as well as patient acceptability with the intervention. A total of 92 of 104 randomised participants (88%) completed the 6-month follow-up. The intervention group demonstrated a more pronounced mean reduction in HbA1c compared to the control group (-1.1% ± 1.1% vs. -0.2% ± 1.2%; adjusted mean difference − 0.9%, 95% CI -1.3 to -0.5; P < 0.001). This clinical improvement coincided with marked improvements in psychosocial and behavioural measures. Culturally grounded fatalistic beliefs were significantly reduced in the intervention group ( P < 0.001), and diabetes knowledge scores increased substantially ( P < 0.001). The proportion of participants with low medication adherence decreased from 64% to 20% in the intervention group, compared to a minimal change in the control group (68% to 62%) ( P < 0.001). Self-care activities, particularly for general diet and blood glucose monitoring, also improved markedly (both P < 0.001). A culturally tailored telehealth education programme was successful in improving glycemic management and key psychosocial and behavioural outcomes among Jordanian adults with T2DM. Randomized Controlled Trials with Registration No. ISRCTN81615946; Date 9th February 2026; retrospectively registered. Trial registration.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: